sulfamic acid has been researched along with D-fructopyranose in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guh, HY; Ko, CY; Micheel, AP | 1 |
| Geisshuesler, S; Klockow-Beck, A; Nick, A; Schaufelberger, D | 1 |
| Chattopadhyay, D; Costanzo, MJ; Maryanoff, BE; Recacha, R | 1 |
| Abbate, F; Antel, J; Casini, A; David, S; Schäfer, S; Scozzafava, A; Supuran, CT; Waldeck, H | 1 |
| Montero, JL; Scozzafava, A; Supuran, CT; Winum, JY | 1 |
| Costanzo, MJ; Hochman, C; Maryanoff, BE; McComsey, DF; Shank, RP; Smith-Swintosky, V | 1 |
| Supuran, CT | 1 |
2 review(s) available for sulfamic acid and D-fructopyranose
| Article | Year |
|---|---|
Sulfamates and their therapeutic potential.
Topics: Amino Acyl-tRNA Synthetases; Animals; Anti-Obesity Agents; Anticonvulsants; Antineoplastic Agents; Antiviral Agents; Carbonic Anhydrases; Escherichia coli; Fructose; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Models, Biological; Models, Chemical; Models, Molecular; Protein Conformation; Protein Isoforms; Steryl-Sulfatase; Sulfonic Acids; Tissue Distribution; Topiramate | 2005 |
Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors.
Topics: Acetazolamide; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Antibodies, Monoclonal; Anticonvulsants; Antineoplastic Agents; Benzodiazepines; Carbonic Anhydrase Inhibitors; Celecoxib; Clinical Trials as Topic; Contraindications; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Fructose; Humans; Isoxazoles; Methazolamide; Phenobarbital; Sulfanilamide; Sulfanilamides; Sulfonamides; Sulfonic Acids; Thiazines; Thiophenes; Topiramate; Zonisamide | 2016 |
5 other study(ies) available for sulfamic acid and D-fructopyranose
| Article | Year |
|---|---|
Ion chromatography method and validation for the determination of sulfate and sulfamate ions in topiramate drug substance and finished product.
Topics: Anticonvulsants; Chromatography, Ion Exchange; Drug Stability; Fructose; Sensitivity and Specificity; Sulfates; Sulfonic Acids; Topiramate | 1998 |
Determination of the inorganic degradation products sulfate and sulfamate in the antiepileptic drug topiramate by capillary electrophoresis.
Topics: Anticonvulsants; Electrophoresis, Capillary; Fructose; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Sulfates; Sulfonic Acids; Topiramate | 1998 |
Crystal structure of human carbonic anhydrase II complexed with an anti-convulsant sugar sulphamate.
Topics: Binding Sites; Carbonic Anhydrase II; Crystallography, X-Ray; Electrons; Fructose; Humans; Ligands; Models, Molecular; Oxygen; Protein Binding; Sulfates; Sulfonic Acids | 2002 |
Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV.
Topics: Animals; Binding Sites; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IV; Cattle; Crystallography, X-Ray; Fructose; Humans; Hydrogen Bonding; Models, Molecular; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids; Topiramate; Zinc | 2003 |
Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform.
Topics: Acidosis; Animals; Anticonvulsants; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Fructose; Humans; Male; Models, Molecular; Molecular Structure; Protein Binding; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids; Topiramate | 2005 |